ADMA Biologics Inc (NASDAQ:ADMA)

4.91
Delayed Data
As of Jun 22
 +0.05 / +1.03%
Today’s Change
2.01
Today|||52-Week Range
5.70
+52.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash17.2M10.4M9.9M44.6M
 
 
 
 
 
Short Term Investment Cash-9.0M-6.8M-526.1K38.7M
 
 
 
 
 
Cash & Short Term Investments21.9M16.8M15.3M44.6M
 
 
 
 
 
 
ReceivablesReceivables384.0K924.5K1.0M3.9M
 
 
 
 
 
 
InventoriesInventories1.7M3.4M5.0M12.6M
 
 
 
 
 
 
Current AssetsPrepaid Expenses143.6K111.0K313.9K--
 
 
 
 
Other Current Assets------2.1M
 
 
Current Assets24.1M21.3M21.7M63.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross4.1M4.2M4.2M31.8M
 
 
 
 
 
Depreciation-1.3M-1.8M-2.2M-1.3M
 
 
 
 
 
Intangible Assets0.000.000.008.4M
 
 
Other Assets298.8K27.2K27.2K10.4M
 
 
 
 
 
Total Assets27.2M23.7M23.7M108.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.8M2.1M2.6M5.9M
 
 
 
 
 
Short Term Debt13.8K15.1K6.1M0.00
 
 
 
 
Accrued Expenses2.2M2.0M2.4M3.3M
 
 
 
 
 
Other Current Liabilities2.4M2.1M2.5M3.5M
 
 
 
 
 
Other Liabilities4.2M4.2M11.2M9.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt15.0M15.7M14.1M43.0M
 
 
 
 
 
Other Liabilities476.8K128.7K98.1K12.7M
 
 
 
 
 
Total Liabilities21.2M22.9M28.1M67.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.00----0.00--
Common Equity6.0M821.0K-4.5M40.3M
 
 
 
 
 
Total Shareholder Equity6.0M821.0K-4.5M40.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding9.3M10.7M12.9M45.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.